WHO’s new contraception guidelines, published on 23 September 2026, support the etonogestrel implant for up to five years, following five-year licences in the US and UK. The change could mean fewer procedures and lower costs for women and health systems,...
Boehringer Ingelheim and the WHO Foundation have launched a US$5m obesity collaboration with no countries named and no commitment to women. Women carry a larger share of the global obesity burden, and existing guidelines already show what a women-aware programme could...
